Letter to the Editor on "Tranexamic Acid Does Not Reduce the Risk of Transfusion in Rheumatoid Arthritis Patients Undergoing Total Joint Arthroplasty"

J Arthroplasty. 2020 Dec;35(12):3777-3778. doi: 10.1016/j.arth.2020.08.007. Epub 2020 Aug 7.

Authors

Songlin Li¹, Qunshan Lu¹, Heran Ma², Peilai Liu¹

Affiliations

¹ Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
² Qilu Cell Therapy Technology Co., Ltd, Jinan, Shandong, People's Republic of China; Shandong Yinfeng Life Science Research Institute, Jinan, Shandong, People's Republic of China.

PMID: 32888751
DOI: 10.1016/j.arth.2020.08.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Antifibrinolytic Agents*
Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / surgery
Arthroplasty
Blood Transfusion
Humans
Tranexamic Acid*

Substances

Antifibrinolytic Agents
Tranexamic Acid